Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses

被引:212
作者
Choi, C
Benveniste, EN
机构
[1] Ewha Womans Univ, Ctr Cell Signaling Res, Seoul 120750, South Korea
[2] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea
[3] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
Fas; Fas ligand; apoptosis; inflammation; immune suppression;
D O I
10.1016/j.brainresrev.2003.08.007
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Apoptosis, also known as programmed cell death, is the major type of cell death involved in normal development, regeneration, proliferation and pathologic degeneration in the central nervous system (CNS). The apoptotic process can be divided further into two pathways depending on the involvement of mitochondria and related biochemical cascades. The internal pathway of apoptosis is initiated by a variety of cytotoxic stimuli and mediated by the release of cytochrome c and subsequent activation of downstream caspases. The external pathway is mainly triggered by ligation of death receptors such as Fas, tumor necrosis factor (TNF)-related apoptosis inducing ligand-R1 (TRAIL-R1), TRAIL-R2 and TNFRp55, and mediated by direct activation of upstream caspases. The Fas-FasL system has been known as a prototypic inducer of extrinsic cell death responsible for cell-mediated cytotoxicity, peripheral immune regulation, immune privilege and "counterattack" of malignant tumor cells against the host immune system. Fas and FasL are expressed in the normal CNS, and expression increases in inflamed and degenerated brains. Like other specialized tissues such as the eye and testis, the Fas-FasL system is thought to be involved in immune suppressed status in the CNS. Expression of Fas and FasL is significantly elevated in a variety of the neurologic disorders, suggesting the possibility that this system may play roles in degenerative and inflammatory responses in the CNS. Therefore, the FasL-Fas system should be considered as a double-edged sword in the CNS: maintaining the immune suppressed status in normal brain and inducing neuronal cell death and inflammation in a variety of neurologic disorders. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:65 / 81
页数:17
相关论文
共 291 条
  • [61] Modulation of experimental allergic encephalomyelitis in Lewis rats by administration of a peptide of Fas ligand
    Ciusani, E
    Gelati, M
    Frigerio, S
    Pollo, B
    Massa, G
    Sacerdote, P
    Panerai, AE
    Salmaggi, A
    [J]. JOURNAL OF AUTOIMMUNITY, 2001, 17 (04) : 273 - 280
  • [62] Connolly K, 2001, J PHARMACOL EXP THER, V298, P25
  • [63] Opposing effect by cytokines on Fas-mediated apoptosis in A549 lung epithelial cells
    Coulter, KR
    Doseff, A
    Sweeney, P
    Wang, YJ
    Marsh, CB
    Wewers, MD
    Knoell, DL
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2002, 26 (01) : 58 - 66
  • [64] Ceramide enables Fas to cap and kill
    Cremesti, A
    Paris, F
    Grassmé, H
    Holler, N
    Tschopp, J
    Fuks, Z
    Gulbins, E
    Kolesnick, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) : 23954 - 23961
  • [65] de la Monte SM, 1998, LAB INVEST, V78, P401
  • [66] Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells
    De Maria, R
    Rippo, MR
    Schuchman, EH
    Testi, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) : 897 - 902
  • [67] Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity
    De Maria, R
    Testi, R
    [J]. IMMUNOLOGY TODAY, 1998, 19 (03): : 121 - 125
  • [68] Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease
    delaMonte, SM
    Sohn, YK
    Wands, JR
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 152 (01) : 73 - 83
  • [69] Deveraux Quinn L., 2001, Cardiology Clinics, V19, P57
  • [70] Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism
    Didenko, VV
    Ngo, HN
    Minchew, C
    Baskin, DS
    [J]. JOURNAL OF NEUROSURGERY, 2002, 96 (03) : 580 - 584